Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517293 | 1.00 | EPHX2 (0.48) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL10193611 | 0.88 | EPHX2 (0.49) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL9709177 | 0.86 | EPHX2 (0.51) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL305796 | 0.86 | EPHX2 (0.47) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL305798 | 0.86 | EPHX2 (0.47) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL9709173 | 0.86 | EPHX2 (0.51) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL6521052 | 0.85 | ALDH1A1 (0.54) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL6521038 | 0.85 | ALDH1A1 (0.54) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL6515143 | 0.80 | EPHX2 (0.46) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL6515492 | 0.79 | ERCC5 (0.51) | ALDH1A1HPGDCYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | EPHX2 661/4885ALDH1A1 1254/4885HPGD 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.